Clinical Trial: Sublobar Wedge Resection or Stereotactic Radiotherapy Treatment of High-risk Patients With Early-stage Lung Cancer

U.S., Feb. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07432802) titled 'Sublobar Wedge Resection or Stereotactic Radiotherapy Treatment of High-risk Patients With Early-stage Lung Cancer' on Jan. 10.

Brief Summary: In low-risk patients with stage I non-small cell lung cancer (NSCLC) surgical treatment with an anatomical resection is currently the standard of care.

For medically inoperable patients with stage I NSCLC, radiation therapy is currently the standard treatment. The latest generation of radiation therapy modalities is Stereotactic Body Radiation Therapy (SBRT).

In high-risk patients, minimal invasive surgery in terms of sublobar resection (wedge resection) with lymph node sampling is currentl...